Search Results - "DE Giacomo, Flavia"

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule by Facondo, Giuseppe, Vullo, Gianluca, De Sanctis, Vitaliana, Vitiello, Cecilia, Nieddu, Luciano, Alfò, Marco, Scaringi, Claudia, De Felice, Francesca, Rotondi, Margherita, De Giacomo, Flavia, Ruscito, Ilary, Valeriani, Maurizio, Falchetto Osti, Mattia

“…Purpose To examine quality of life (QOL) and sexual functioning in a series of patients with intermediate- and high-intermediate risk endometrial cancer,…”
Get full text

Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study by Lupattelli, Marco, Palazzari, Elisa, Polesel, Jerry, Chiloiro, Giuditta, Angelicone, Ilaria, Panni, Valeria, Caravatta, Luciana, Di Biase, Saide, Macchia, Gabriella, Niespolo, Rita Marina, Franco, Pierfrancesco, Epifani, Valeria, Meldolesi, Elisa, de Giacomo, Flavia, Lucarelli, Marco, Montesi, Giampaolo, Mantello, Giovanna, Innocente, Roberto, Osti, Mattia Falchetto, Gambacorta, Maria Antonietta, Aristei, Cynthia, De Paoli, Antonino

“…Despite the feasibility and promising activity data on intensity-modulated RT and simultaneous integrated boost (IMRT-SIB) dose escalation in preoperative…”
Get full text

Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study by DE Sanctis, Vitaliana, DI Rocco, Alice, Cox, Maria Christina, Valeriani, Maurizio, Congedi, Francesca Perrone, Anzellini, Dimitri, Massaro, Maria, Vullo, Gianluca, Facondo, Giuseppe, DE Giacomo, Flavia, Alfò, Marco, Prosperi, Daniela, Pizzichini, Patrizia, Pelliccia, Sabrina, Tafuri, Agostino, Martelli, Maurizio, Osti, Mattia Falchetto

“…To evaluate the efficacy of residual site radiation therapy (RSRT) on local control (LC), progression-free (PFS) and overall (OS) survival in patients with…”
Get full text